Skip to main content
Full access
LETTER
Published Online: 1 October 2010

Delayed Huntington’s Disease Diagnosis in Two Alcoholic Patients With a Family History of “Parkinson’s Disease”

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Huntington’s disease is an autosomal dominant neurodegenerative disease characterized by a triad of symptoms and signs including movement disorder, cognitive impairment, and behavioral syndromes. 1 As the earliest pathological changes in Huntington’s disease are in the associative portion of the striatum, the domains first affected by the disease may be cognitive and psychiatric rather than motor. 2, 3

Case Report

A 51-year-old woman with a history of alcohol abuse, though abstinent for 3 years, presented with cognitive deterioration. She could no longer teach properly because she forgot what to say, was unable to repeat information, could no longer handle money, and didn′t know how to cook or take care of the house. On one occasion she tried to spice the salad with liquid soap and put the mobile phone in the refrigerator. She also complained of irritability, aggressive outbursts, sadness, anxiety, restlessness, and hyperphagia with a preference for sweet foods. These symptoms evolved over the last 10 years. In the previous 3 years, after being hospitalized for alcohol detoxification, she started noticing unsteady gait with frequent falls and involuntary movements, especially in her lower limbs, which would frequently kick even when she was lying down.
Her family history included what was called “Parkinson’s disease” in her mother, grandmother and two maternal uncles. The patient also had a 52-year-old sister who was receiving psychiatric treatment for alcohol abuse and depressive syndrome and who had recent presented behavioral changes including agitation, anxiety, overactivity, and frequent falls.
Neurological examination of the patient showed severe akathisia with noticeable lower-limb predominant choreiform movements and discrete motor perseveration. Her Mini-Mental State Examination score was 23.
An analytic study, including CBC, vitamin B 12 and folic acid levels, thyroid, and hepatic functions revealed no abnormalities in our patient. A brain MRI showed generalized brain atrophy especially in the frontal lobe. Neuropsychological study revealed dementia in an early stage with frontotemporal characteristics. Genetic testing for Huntington’s disease was positive, as it was also positive for our patient’s oldest sister. The patient’s daughter decided to do the presymptomatic test for Huntington’s disease and had also the abnormal expansion in the gene.

Discussion

Glutamate excitotoxicity has been implicated in the pathophysiology of movement disorder and other manifestations of Huntington’s disease. Alcohol has been shown to inhibit NMDA receptors in rats and mice as well as to retard progression of Huntington’s disease disorder in humans. 4 Chronic NMDA inhibition has also been reported to lead to NMDA upregulation, increasing the risk of glutamate excitotoxicity. 4 Thus, alcohol intake may initially inhibit NMDA receptors and mask Huntington’s disease manifestations, but chronic alcohol use may lead to receptor upregulation, resulting in NMDA excitotoxicity and manifestation of Huntington’s disease. 4
Huntington’s disease patients can present with rigidity without signs of chorea. Such individuals can be misdiagnosed with Parkinson’s disease, catatonia, or schizophrenia. 5 This might have been the case with this patient’s mother and grandmother, both of whom died with cognitive deterioration and movement abnormalities.
This case highlights the importance of a careful family history, as the presence of disease in multiple members of the same family can be a fundamental clue for a genetic cause and help to make the correct diagnosis.

References

1.
Anderson KE, Marder KS: An overview of psychiatric symptoms in Huntington’s disease. Curr Psychiatr Rep 2001; 3:379–388
2.
Paulsen JS, Ready RE, Hamilton JM, et al: Neuropsychiatric aspects of Huntington’s disease. J Neurol Neurosurg Psychiatry 2001; 71:310–314
3.
Duijn EV, Kingma EM, Mast RC: Psychopathology in verified Huntington’s disease gene carriers. J Neuropsychiatry Clin Neurosci 2007; 19:441–447
4.
Matoo SK, Khurana H: Huntington′s disease and alcohol abuse. Neurol India 1999; 47:68–70
5.
Walker FO: Huntington′s disease. Lancet 2007; 369:218–228

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 451.e2
PubMed: 21037133

History

Published online: 1 October 2010
Published in print: Fall, 2010

Authors

Affiliations

Luísa Silva, M.D.
Psychiatry and Mental Health Department, Hospital de São Marcos, Braga, Portugal
Álvaro Machado, M.D.
Neurology Department, Hospital de São Marcos, Braga, Portugal

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share